PL3137059T3 - Metoda wytwarzania płynnych zawiesin farmaceutycznych zawierających bizmut - Google Patents
Metoda wytwarzania płynnych zawiesin farmaceutycznych zawierających bizmutInfo
- Publication number
- PL3137059T3 PL3137059T3 PL15724823T PL15724823T PL3137059T3 PL 3137059 T3 PL3137059 T3 PL 3137059T3 PL 15724823 T PL15724823 T PL 15724823T PL 15724823 T PL15724823 T PL 15724823T PL 3137059 T3 PL3137059 T3 PL 3137059T3
- Authority
- PL
- Poland
- Prior art keywords
- containing liquid
- liquid pharmaceutical
- pharmaceutical suspensions
- making bismuth
- bismuth
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
- A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/29—Antimony or bismuth compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461985653P | 2014-04-29 | 2014-04-29 | |
| EP15724823.8A EP3137059B1 (en) | 2014-04-29 | 2015-04-29 | Method for making bismuth-containing liquid pharmaceutical suspensions |
| PCT/US2015/028215 WO2015168241A1 (en) | 2014-04-29 | 2015-04-29 | Method for making bismuth-containing liquid pharmaceutical suspensions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3137059T3 true PL3137059T3 (pl) | 2018-10-31 |
Family
ID=53267574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15724823T PL3137059T3 (pl) | 2014-04-29 | 2015-04-29 | Metoda wytwarzania płynnych zawiesin farmaceutycznych zawierających bizmut |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US9486436B2 (pl) |
| EP (1) | EP3137059B1 (pl) |
| CN (1) | CN106255495B (pl) |
| AU (1) | AU2015253187B2 (pl) |
| CA (2) | CA3041501C (pl) |
| ES (1) | ES2682210T3 (pl) |
| MX (1) | MX370908B (pl) |
| PL (1) | PL3137059T3 (pl) |
| RU (1) | RU2694530C2 (pl) |
| WO (1) | WO2015168241A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3134081B1 (en) | 2014-04-23 | 2020-04-22 | The Procter and Gamble Company | Cyclohexanecarboxamide with cooling properties |
| WO2015168242A1 (en) * | 2014-04-29 | 2015-11-05 | The Procter & Gamble Company | Bismuth-containing liquid pharmaceutical suspensions |
| MX370908B (es) * | 2014-04-29 | 2020-01-08 | Procter & Gamble | Metodo para fabricar suspensiones farmaceuticas liquidas que contienen bismuto. |
| WO2017037706A1 (en) * | 2015-08-31 | 2017-03-09 | Zelikman Vadim | An appartus for dispensing a predefined dosage form |
| WO2019040878A1 (en) | 2017-08-25 | 2019-02-28 | L. Perrigo Company | PHARMACEUTICAL SUSPENSIONS FOR BISMUTH SUBSALICYLATES |
| FR3089392B1 (fr) * | 2018-12-07 | 2021-12-31 | Oenotropic Innovation | Utilisation d’un polysaccharide et d’un compose soufre pour la mise en suspension de particules dans une composition liquide |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1269987A (en) | 1968-04-18 | 1972-04-12 | Garland Richard Brown | Antacid composition |
| US4801454A (en) * | 1986-07-17 | 1989-01-31 | The Proctor & Gamble Company | Processes for making colored pharmaceutical compositions |
| US5013560A (en) * | 1989-03-17 | 1991-05-07 | The Procter & Gamble Company | Microbially-stable bismuth-containing liquid pharmaceutical suspensions |
| US20010016577A1 (en) * | 1998-08-24 | 2001-08-23 | Douglas Joseph Dobrozsi | Oral mucoadhesive compositions containing gastrointestinal actives |
| US6482865B1 (en) | 2000-04-12 | 2002-11-19 | Gastropal Partners | Method for preparing colloidal solution of bismuth sodium tartrate |
| US6712496B2 (en) * | 2001-07-26 | 2004-03-30 | The Procter & Gamble Company | Auger fed mixer apparatus and method of using |
| WO2003066022A2 (en) * | 2002-02-04 | 2003-08-14 | Pharmacia Corporation | Stable pharmaceutical composition useful for treating gastrointestinal disorders |
| KR20040089628A (ko) * | 2002-03-04 | 2004-10-21 | 가부시키가이샤 메드렉스 | 생체내에서 상전이하는 액상 매트릭스 및 액상 경구 제제 |
| GB0507167D0 (en) * | 2005-04-08 | 2005-05-18 | Glaxosmithkline Consumer Healt | Composition |
| MX319376B (es) | 2006-03-22 | 2014-04-11 | Procter & Gamble | Composicion liquida de tratamiento. |
| US20080008814A1 (en) * | 2006-06-22 | 2008-01-10 | Philip Henry Jackson | Acidified Protein Beverages Containing Suspended Particulates and Methods of Making Same |
| US20080227892A1 (en) | 2007-03-13 | 2008-09-18 | Van Der Wielen Maarten | Paint formulations comprising cellulose ether/network building polymer fluid gel thickeners |
| EP2158028B1 (en) * | 2007-06-28 | 2012-11-14 | The Procter & Gamble Company | Apparatus and method for mixing by producing shear and cavitation in a liquid |
| US8394752B2 (en) | 2008-12-18 | 2013-03-12 | The Procter & Gamble Company | Pearlescent agent slurry for liquid treatment composition |
| MX370908B (es) * | 2014-04-29 | 2020-01-08 | Procter & Gamble | Metodo para fabricar suspensiones farmaceuticas liquidas que contienen bismuto. |
| WO2015168242A1 (en) * | 2014-04-29 | 2015-11-05 | The Procter & Gamble Company | Bismuth-containing liquid pharmaceutical suspensions |
-
2015
- 2015-04-29 MX MX2016013884A patent/MX370908B/es active IP Right Grant
- 2015-04-29 CN CN201580022962.XA patent/CN106255495B/zh active Active
- 2015-04-29 WO PCT/US2015/028215 patent/WO2015168241A1/en active Application Filing
- 2015-04-29 CA CA3041501A patent/CA3041501C/en active Active
- 2015-04-29 CA CA2943420A patent/CA2943420C/en active Active
- 2015-04-29 US US14/698,962 patent/US9486436B2/en active Active
- 2015-04-29 PL PL15724823T patent/PL3137059T3/pl unknown
- 2015-04-29 EP EP15724823.8A patent/EP3137059B1/en active Active
- 2015-04-29 ES ES15724823.8T patent/ES2682210T3/es active Active
- 2015-04-29 AU AU2015253187A patent/AU2015253187B2/en active Active
- 2015-04-29 RU RU2016137537A patent/RU2694530C2/ru not_active IP Right Cessation
-
2016
- 2016-10-10 US US15/289,470 patent/US10034888B2/en active Active
-
2018
- 2018-06-28 US US16/021,502 patent/US10532063B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN106255495B (zh) | 2019-10-22 |
| WO2015168241A1 (en) | 2015-11-05 |
| EP3137059B1 (en) | 2018-05-23 |
| BR112016025072A8 (pt) | 2021-07-06 |
| MX370908B (es) | 2020-01-08 |
| CA2943420C (en) | 2019-06-25 |
| EP3137059A1 (en) | 2017-03-08 |
| US9486436B2 (en) | 2016-11-08 |
| RU2016137537A (ru) | 2018-05-29 |
| RU2694530C2 (ru) | 2019-07-16 |
| RU2016137537A3 (pl) | 2018-05-29 |
| CA3041501C (en) | 2020-09-22 |
| MX2016013884A (es) | 2017-02-02 |
| BR112016025072A2 (pt) | 2017-08-15 |
| US20150306061A1 (en) | 2015-10-29 |
| CA2943420A1 (en) | 2015-11-05 |
| CN106255495A (zh) | 2016-12-21 |
| US20170027964A1 (en) | 2017-02-02 |
| US10532063B2 (en) | 2020-01-14 |
| AU2015253187A1 (en) | 2016-10-13 |
| AU2015253187B2 (en) | 2017-10-05 |
| US20180303852A1 (en) | 2018-10-25 |
| US10034888B2 (en) | 2018-07-31 |
| ES2682210T3 (es) | 2018-09-19 |
| CA3041501A1 (en) | 2015-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201406151D0 (en) | Method | |
| GB201406155D0 (en) | Method | |
| GB201517013D0 (en) | Differential headtracking apparatus | |
| PL3227023T3 (pl) | Sposób wytwarzania kropel | |
| EP3171179A4 (en) | Liquid stirring method | |
| PL3196196T3 (pl) | Sposób wytwarzania kalcobutrolu | |
| PL3137059T3 (pl) | Metoda wytwarzania płynnych zawiesin farmaceutycznych zawierających bizmut | |
| IL250488A0 (en) | A method for producing lanthanide nanoparticles | |
| GB201403470D0 (en) | Method | |
| HK1243993A1 (zh) | 液體淨化系統 | |
| PL3169844T3 (pl) | Sposób zapobiegania tworzeniu się kamienia kotłowego | |
| SG11201607948VA (en) | Filtering apparatus | |
| GB201403568D0 (en) | Dense media deparation method | |
| PL3137056T3 (pl) | Ciekłe zawiesiny farmaceutyczne zawierające bizmut | |
| PT3046590T (pt) | Processo para preparar um preparado farmacêutico líquido | |
| SG10201503704QA (en) | Method for mixing fluids | |
| PT3380668T (pt) | Dispositivo de moagem | |
| EP3315287A4 (en) | Container manufacturing apparatus | |
| EP2931906A4 (en) | PROCESS FOR PRODUCING FURFURAL | |
| KR102221837B9 (ko) | 차선 변경 장치 | |
| GB201421962D0 (en) | Filtration method | |
| GB201415777D0 (en) | Filter apparatus | |
| GB201520106D0 (en) | Method for transferring fluid | |
| GB201414181D0 (en) | Method | |
| ZA201702526B (en) | Chassis & method |